Evaluation Method Demonstrates Effective Quality Control of Lipid Nanoparticles, Suggesting Improved Drug Safety.
The quality assurance of lipid nanoparticles (LNPs) is important for the effectiveness and safety of drugs. We developed a simple high-performance liquid chromatography (HPLC) method for rapid quality assessment of LNPs. LNPs prepared by a microchemical process were analyzed using a Tris gradient mobile phase and a poly-Lys–modified monolith as the stationary phase. This analysis produced two peaks at ~ 1 and 5 min. The fractions were collected and examined for particle morphology and zeta potential. The 1-min peak contained 20–40 nm nanoparticles, while the 5-min peak corresponded to LNPs. We applied this method to evaluate LNP stability after dilution with Tris buffer and exposure to 100 mM Ca²⁺. LNPs degraded within 1 day in Ca²⁺ at 4 °C, but > 85% remained intact after 3 days in a 500-fold Tris buffer dilution. This method enables LNP analysis within 10 min and provides a useful tool for LNP quality control.
No takes yet. Share an insight, caveat, or question.
Murayama et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: